Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

The New York Times - Business:

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

This post first appeared in The New York Times - Business. Read the original article.